Pancreatic Cancer Pathway

Normal duct epithelium progresses to infiltrating cancer through a series of histologically defined precursors (PanINs). The overexpression of HER-2/neu and activating point mutations in the K-ras gene occur early, inactivation of the p16 gene at an intermediate stage, and the inactivation of p53, SMAD4, and BRCA2 occur relatively late. Activated K-ras engages multiple effector pathways. Although EGF receptors are conventionally regarded as upstream activators of RAS proteins, they can also act as RAS signal transducers via RAS-induced autocrine activation of the EGFR family ligands. Pancreatic ductal adenocarcinoma (PDA) show elevated expression of EGF receptors (e.g. HER2/neu) and their ligands (e.g. TGF-alpha) consistent with the presence of this autocrine loop. Moreover, PDA shows extensive genomic instability and aneuploidy. Telomere attrition and mutations in p53 and BRCA2 are likely to contribute to these phenotypes. Inactivation of the SMAD4 tumour suppressor gene leads to loss of the inhibitory influence of the transforming growth factor-beta signaling pathway. (NCI Thesaurus/KEGG)

YOU MAY ALSO LIKE

Pancreatic Cancer

A disease in which malignant (cancer) cells are found in the tissues of the pancreas. Also called exocrine cancer.

Pancreatic Beta Cell Adenoma

An adenoma arising from the beta cells of the pancreas. It produces insulin.

Pancreatic Anastomotic Leakage

Leakage due to breakdown of a pancreatic anastomosis.

Pancreatic Amylase Measurement

The determination of the amount of pancreatic amylase present in a sample.

Pancreatic Alpha Cell Adenoma

A benign endocrine neoplasm arising from the alpha cells of the pancreas. It produces glucagon.

Pancreatic Adenosquamous Carcinoma

A carcinoma that arises from the pancreas showing both ductal and squamous differentiation. The squamous component should represent at least 30%…